TP53 and acute myeloid leukemia: Indeed, more than 50% of all human cancers present mutations in TP53, especially in ovarian, colorectal, and small cell lung cancers, while there are clearly fewer in acute myeloid leukemia (AML), thyroid, and bone cancers.